Zosen Lab · Developmental neurotoxicology · Neural differentiation · Human organoids · Brain disorders

From one cell to a human brain.

We study how the human nervous system builds itself, how medicines and the environment can change that, and how to turn what we learn in human cells into knowledge the clinic can use.

Each line is one cell. The marks along it are a record of what happened to it on the way.

Principal investigator
Denis Zosen, PhD, MBA
Host
Norwegian Centre for Molecular Biosciences and Medicine (NCMBM), University of Oslo
Models
Human iPSC · brain organoids · neuronal cell lines · clinical relevance
Status
Independent research programme, founding phase 2026 to 2027. Open to collaboration and joint grant applications
Denis Zosen pipetting into a culture plate in a cell culture hood

Principal investigator

Hello, I'm Denis Zosen

I am a molecular cell biologist and neuroscientist with a PhD from the University of Oslo and an MBA. Alongside research I have worked in industry innovation, health-technology projects and clinical research, where I led teams and took on operational and financial coordination. Now I am building my own research programme in academia.

It starts with how drugs and pollutants change the developing human brain. It reaches toward neuropathologies and any other question that human organoids and cells can answer, and it follows that question one cell at a time.

The group is new, so I can offer what a large lab cannot: close supervision and a say in the programme. I back the people I work with at the bench, in the writing, with funding, and with the practical side of working in Oslo. How I support you

About me Email me

Who this site is for

Pick the door that fits you.

Students and researchers

Master's, PhD and postdoctoral candidates interested in human organoid models of brain development and neuropathologies.

How to join the lab

Academic collaborators

Groups working on organoids, developmental neurotoxicology, neuropathologies, single-cell methods or clinical questions.

Collaborate with us

Industry and policy

Teams that need human-cell evidence on how medicines and exposures affect the developing brain, and on how neuropathologies arise.

For industry and policy

What we work on

Three connected areas, studied in human cells and tissue.

How the nervous system is built

How stem cells become neurons, how neural tissue organises itself, and what sets the timing. We grow human brain and spinal cord tissue from stem cells to follow it.

What can change it

Medicines and environmental exposures reach the developing brain at different doses and at different stages. We ask what they alter, and why results differ between systems.

From the dish to the clinic

Evidence from human tissue, careful enough to inform decisions about medicines and exposures, with fewer animal experiments.

More on the research page

Selected findings

Three results that set the direction. All papers are open to read through their DOI.

2021 · first author

Drugs reach the developing brain within minutes

A chicken embryo model shows how much of a drug arrives, and when, without pregnant animals.

Read the paper

2023 · first author

A reassuring marker can hide harm

Two antidepressants raised a protective signal in human neurons while one of them cut neurite growth.

Read the paper

2026 · second author

Spinal cord organoids mature like real neurons

To our knowledge, the first electrophysiological check of human stem-cell-derived spinal cord tissue.

Read the paper

All publications

One question, followed for ten years

My work traces how neural tissue builds itself and how drugs and the environment alter that, across four countries, two model systems and a move from signalling pathways to single cells.

See the research path

Track record

Counts from my publication record. Citation figures are on Google Scholar, and the full record is on ORCID.

12Peer-reviewed papers
5As first author
4Countries worked in
~€300KFunding won as applicant

Recent

  • Joined three Working Groups (WG1, WG2, WG4) of COST Action EndLess, a European network on early-life exposure to endocrine disruptors.
  • Preprint on what DNA recorders can resolve in human cortical organoids, with the simulator and code: The writable window.
  • Guest Researcher at the Norwegian Centre for Molecular Biosciences and Medicine, the Norwegian node of the Nordic EMBL Partnership.
  • Spinal cord organoid paper published in ACS Chemical Neuroscience. To our knowledge, it is the first electrophysiological assessment of neuronal maturation in this system.

All news

Replacing animal experiments

Two of my first-author papers exist because pregnant patients are excluded from trials and the evidence has to come from models that do not use mammals. Our current work uses human tissue only.

Organoids that earn their relevance

A brain organoid is a model, and it lacks blood vessels, immune cells and the maturity of an adult brain. We test it before we trust it: neurons are checked against real physiology, doses are anchored to measured human exposure, and every question gets more than one readout.

Open and checkable

Protocols, code and decision criteria are written down before the results arrive, and shared where we can.

Start with a short email

Whether you want to join, collaborate or just ask a question, tell me in two or three lines what you have in mind. I reply to every message.

Bring your own funding Join the lab Collaborate Email me